These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 16275052)

  • 1. High lung deposition of 99mTc-labeled ciclesonide administered via HFA-MDI to patients with asthma.
    Newman S; Salmon A; Nave R; Drollmann A
    Respir Med; 2006 Mar; 100(3):375-84. PubMed ID: 16275052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower oropharyngeal deposition of inhaled ciclesonide via hydrofluoroalkane metered-dose inhaler compared with budesonide via chlorofluorocarbon metered-dose inhaler in healthy subjects.
    Nave R; Zech K; Bethke TD
    Eur J Clin Pharmacol; 2005 May; 61(3):203-8. PubMed ID: 15824911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-dimensional and three-dimensional imaging show ciclesonide has high lung deposition and peripheral distribution: a nonrandomized study in healthy volunteers.
    Leach CL; Bethke TD; Boudreau RJ; Hasselquist BE; Drollmann A; Davidson P; Wurst W
    J Aerosol Med; 2006; 19(2):117-26. PubMed ID: 16796536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equivalent pharmacokinetics of the active metabolite of ciclesonide with and without use of the AeroChamber Plus spacer for inhalation.
    Drollmann A; Nave R; Steinijans VW; Baumgärtner E; Bethke TD
    Clin Pharmacokinet; 2006; 45(7):729-36. PubMed ID: 16802853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the oropharyngeal deposition of inhaled ciclesonide and fluticasone propionate in patients with asthma.
    Richter K; Kanniess F; Biberger C; Nave R; Magnussen H
    J Clin Pharmacol; 2005 Feb; 45(2):146-52. PubMed ID: 15647406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of ciclesonide and desisobutyryl ciclesonide after administration via aqueous nasal spray or hydrofluoroalkane nasal aerosol compared with orally inhaled ciclesonide: an open-label, single-dose, three-period crossover study in healthy volunteers.
    Nave R; Herzog R; Laurent A; Wingertzahn MA
    Clin Ther; 2009 Dec; 31(12):2988-99. PubMed ID: 20110036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic disposition of inhaled ciclesonide and its metabolite desisobutyryl-ciclesonide in healthy subjects and patients with asthma are similar.
    Nave R; Gunawardena KA; Zech K; Bethke TD
    Int J Clin Pharmacol Ther; 2006 Jan; 44(1):1-7. PubMed ID: 16425964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Respiratory Tract Deposition of HFA-Beclomethasone and HFA-Fluticasone in Asthmatic Patients.
    Leach CL; Kuehl PJ; Chand R; McDonald JD
    J Aerosol Med Pulm Drug Deliv; 2016 Apr; 29(2):127-33. PubMed ID: 26061801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deposition and metabolism of inhaled ciclesonide in the human lung.
    Nave R; Watz H; Hoffmann H; Boss H; Magnussen H
    Eur Respir J; 2010 Nov; 36(5):1113-9. PubMed ID: 20351025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated-dose pharmacokinetics of inhaled ciclesonide (CIC-HFA) in Japanese children with bronchial asthma: a phase I study.
    Teramoto T; Matsui E; Fukao T; Sakai K; Yonezawa H; Kato Z; Ohnishi H; Kaneko H; Kondo N; Azuma J; Nishima S
    Allergol Int; 2012 Dec; 61(4):619-24. PubMed ID: 23000724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of lung deposition following inhalation of ciclesonide using different bioanalytical procedures.
    Nave R
    Bioanalysis; 2010 Apr; 2(4):807-14. PubMed ID: 21083275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacokinetic and pharmacodynamic profile of inhaled ciclesonide.
    Nave R
    Clin Pharmacokinet; 2009; 48(4):243-52. PubMed ID: 19492869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visualizing the spatial localization of ciclesonide and its metabolites in rat lungs after inhalation of 1-μm aerosol of ciclesonide by desorption electrospray ionization-time of flight mass spectrometry imaging.
    Yamamoto E; Taquahashi Y; Kuwagata M; Saito H; Matsushita K; Toyoda T; Sato F; Kitajima S; Ogawa K; Izutsu KI; Saito Y; Hirabayashi Y; Iimura Y; Honma M; Okuda H; Goda Y
    Int J Pharm; 2021 Feb; 595():120241. PubMed ID: 33484917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ciclesonide -- a new inhaled corticosteroid].
    Ukena D
    Pneumologie; 2005 Oct; 59(10):689-95. PubMed ID: 16222581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics and pharmacodynamics of inhaled ciclesonide and fluticasone propionate in patients with persistent asthma.
    Xu J; Nave R; Lahu G; Derom E; Derendorf H
    J Clin Pharmacol; 2010 Oct; 50(10):1118-27. PubMed ID: 20150524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Respiratory deposition patterns of salbutamol pMDI with CFC and HFA-134a formulations in a human airway replica.
    Cheng YS; Fu CS; Yazzie D; Zhou Y
    J Aerosol Med; 2001; 14(2):255-66. PubMed ID: 11681657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors Determining In Vitro Lung Deposition of Albuterol Aerosol Delivered by Ventolin Metered-Dose Inhaler.
    Biswas R; Hanania NA; Sabharwal A
    J Aerosol Med Pulm Drug Deliv; 2017 Aug; 30(4):256-266. PubMed ID: 28157430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional lung deposition of a technetium 99m-labeled formulation of mometasone furoate administered by hydrofluoroalkane 227 metered-dose inhaler.
    Pickering H; Pitcairn GR; Hirst PH; Bacon PR; Newman SP; Affrime MB; Marino M
    Clin Ther; 2000 Dec; 22(12):1483-93. PubMed ID: 11192139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of hydrofluoroalkane formulations of ciclesonide 400 microg once daily vs fluticasone 250 microg twice daily on methacholine hyper-responsiveness in mild-to-moderate persistent asthma.
    Lee DK; Haggart K; Currie GP; Bates CE; Lipworth BJ
    Br J Clin Pharmacol; 2004 Jul; 58(1):26-33. PubMed ID: 15206989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ciclesonide: a review of its use in the management of asthma.
    Deeks ED; Perry CM
    Drugs; 2008; 68(12):1741-70. PubMed ID: 18681495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.